Essphar Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.10 M
as on 16-11-2024
- Revenue 689.46%
(FY 2023)
- Profit 10.30%
(FY 2023)
- Ebitda 134.87%
(FY 2023)
- Net Worth 64.75%
(FY 2023)
- Total Assets 128.62%
(FY 2023)
About Essphar
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.10 M.
Ashok Sahu, Bikrama Panda, and Sanjay Nayak serve as directors at the Company.
- CIN/LLPIN
U24119MH2020PTC345189
- Company No.
345189
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Essphar?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Sahu  | Director | 22-Apr-2022 | Current |
| Bikrama Panda | Director | 18-Jan-2023 | Current |
| Sanjay Nayak | Director | 17-May-2021 | Current |
Financial Performance and Corporate Structure Insights of Essphar.
Essphar Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 689.46% increase. The company also saw a substantial improvement in profitability, with a 10.3% increase in profit. The company's net worth Soared by an impressive increase of 64.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Essphar?
Unlock access to Essphar's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Niyama Pharmaceuticals Private LimitedActive 6 years 15 days
Ashok Sahu and Sanjay Nayak are mutual person
- Rapti Gangasagar Infrastructure Private LimitedActive 7 years 4 months
Ashok Sahu is a mutual person
- Wave Riser Marine And Engineering Private LimitedActive 2 years 15 days
Bikrama Panda is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Abhyudaya Co-Operative Bank Limited Creation Date: 17 Aug 2022 | ₹1.80 M | Open |
Abhyudaya Co-Operative Bank Limited Creation Date: 30 Jul 2022 | ₹3.30 M | Open |
How Many Employees Work at Essphar?
Essphar has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Essphar, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Essphar's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
